ArticleVeterinary research communications2026
Enhancing Alcelaphine gammaherpesvirus 1 propagation in the MDBK cell line: role of ruxolitinib and reduced incubation temperature.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alcelaphine gammaherpesvirus 1 (AlHV-1) is the causative agent of malignant catarrhal fever, a fatal disease of cattle prevalent in regions with wildebeest populations. In vitro isolation and propagation of AlHV-1 is laborious and often requires multiple passages to improve the visibility of the cytopathic effect in host cells and increase virus yields. Ruxolitinib increases the replication of some viruses due to inhibition of the IFN-induced antiviral response of infected cells. In this study, the effect of a ruxolitinib-enriched culture medium was tested simultaneously with the effect of a reduced incubation temperature (33 °C) on the propagation of the AlHV-1 strain WC-11 adapted to the MDBK cell line. Ruxolitinib significantly increased the destruction of the cell monolayer during AIHV-1 propagation and significantly increased the virus titre. In addition, the amount of cell-free AIHV-1 particles in the culture medium was enhanced significantly in the presence of ruxolitinib. A reduced incubation temperature (33 °C), either in combination with ruxolitinib-enriched medium or without ruxolitinib, had no significant effect on AIHV-1 growth. These results demonstrate that ruxolitinib enhances the propagation of AlHV-1 strain WC-11 and suggest a broader potential to improve the efficiency of AlHV-1 cell culture-based applications, such as virus isolation, vaccine production, and diagnostics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.